PeptideDB

NBD-556 333353-44-9

NBD-556 333353-44-9

CAS No.: 333353-44-9

NBD-556, a CD4 mimetic, is a potent HIV-1 entry inhibitor that blocks gp120-CD4 interaction. NBD-556 displays potent cel
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

NBD-556, a CD4 mimetic, is a potent HIV-1 entry inhibitor that blocks gp120-CD4 interaction. NBD-556 displays potent cell fusion and virus-cell fusion inhibitory activity at low micromolar levels.

Physicochemical Properties


Molecular Formula C17H24CLN3O2
Molecular Weight 337.848
Exact Mass 337.156
CAS # 333353-44-9
Related CAS # 333353-44-9;NBD-556 HCl;
PubChem CID 1570601
Appearance Typically exists as solid at room temperature
LogP 4.073
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 2
Heavy Atom Count 23
Complexity 441
Defined Atom Stereocenter Count 0
SMILES

O=C(C(NC1CC(C)(NC(C)(C1)C)C)=O)NC2=CC=C(C=C2)Cl

InChi Key ZKXLQCIOURANAD-UHFFFAOYSA-N
InChi Code

InChI=1S/C17H24ClN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23)
Chemical Name

N'-(4-chlorophenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)oxamide
Synonyms

NBD556; NBD 556; NBD-556
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro NBD-556 (1-100 μM) suppresses the fusion of cells and viruses mediated by the HIV-1 envelope [1]. The laboratory-adapted HIV-1 IIIB, MN, and V32 strains are inhibited from infecting MT-2 cells by NBD-556, with IC50 values of 6.5, 15.9, and 5.3 µM, respectively [1]. NBD-556 (1-100 μM) has an IC50 of 22.6 μM and suppresses CD4-dependent viruses in a dose-dependent manner [1].
References [1]. Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology. 2005 Sep 1;339
[2]. Schon A, et al. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Biochemistry. 2006 Sep 12;45(36):10973-10980.

Solubility Data


Solubility (In Vitro) DMSO : ~33.33 mg/mL (~98.66 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.40 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.9599 mL 14.7995 mL 29.5989 mL
5 mM 0.5920 mL 2.9599 mL 5.9198 mL
10 mM 0.2960 mL 1.4799 mL 2.9599 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.